Financials

News Discussions Technicals Seasonals

206650 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

EuBiologics Co., Ltd. engages in the research, development, and manufacture of biopharmaceutical products. It offers comprehensive contract research organization and contract manufacturing organization services. Its products include Euvichol, oral cholera vaccine, enteric infection vaccine, and anti-cancer vaccine. The company was founded on March 10, 2010 and is headquartered in Seoul, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

206650 does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company